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Abstract
Gastrointestinal disease is omnipresent in captive cheetahs (Acinonyx jubatus), in contrast to its free-
ranging populations. The current study aimed to evaluate the effect of diet type (meat-only whole 
prey) on gastrointestinal health in captive cheetahs by measuring faecal and serum concentrations of 
S100/calgranulins. This paper reports faecal S100A12 and calprotectin concentrations in 12 captive 
cheetahs fed supplemented beef versus whole rabbit for one month in a cross-over design. Also, 
serum S100A12 and calprotectin concentrations were determined in four cheetahs fed whole rabbit 
and six cheetahs fed supplemented beef, and these were compared to the faecal concentrations of 
the respective marker proteins. Both the immunoassay for canine calprotectin and canine S100A12 
were precise and reproducible for use with serum samples and faecal extracts. Whereas the assay 
for S100A12 was linear and accurate, an inconsistent linearity of the canine calprotectin assay was 
observed and could be indicative of an insufficient cross-reactivity of the specific antibody used for 
this assay. Serum concentrations of S100A12 and calprotectin were not altered by diet type, and were 
not correlated with the respective concentrations in faeces. Numerically (P=0.241) greater calprotectin 
concentrations and greater (P=0.041) faecal S100A12 concentrations were detected in cheetahs fed 
supplemented beef compared with whole rabbit. These findings demonstrate that whole prey feeding 
may decrease intestinal inflammation in the captive cheetah. Consequently, the relation between diet 
type and intestinal inflammatory conditions in the captive cheetah warrants further investigation.
Introduction
The prevalence of gastrointestinal disease is high in the 
captive cheetah (Acinonyx jubatus) compared to the wild 
population (Munson 1993; Munson et al. 1999, 2005; Kotsch 
et al. 2002). The type of diet offered to captive cheetahs has 
been implicated as a potential factor in gastro-intestinal 
disease in this species (Whitehouse-Tedd 2012). Recently, 
we demonstrated that the type of a strict carnivorous diet 
modulates microbial fermentation processes in the cheetah 
(Depauw et al. 2011). Cheetahs fed a supplemented beef diet 
were observed to have significantly higher concentrations of 
faecal putrefactive compounds, accompanied by looser stool 
and a higher incidence of diarrhoea as compared to the same 
cheetahs fed whole rabbit. In contrast, faecal concentrations of 
total short-chain fatty acids (SCFA) were unaltered by diet type 
(Depauw et al. 2011). These differences in fermentation were 
attributed to the relatively high intake of animal fibre (bone, 
fur, connective tissue), in combination with a reduced protein 
intake, of whole prey compared with meat-only diets (Depauw 
et al. 2011). 
Whereas SCFAs are generally associated with important 
beneficial effects on intestinal function and metabolism (Wong 
et al. 2006), putrefactive compounds are commonly linked with 
chronic intestinal inflammatory diseases (Weber et al. 1987; 
Matsui et al. 1995; Pedersen et al. 2002; Tuohy et al. 2006). As 
such, Depauw et al. (2011) postulated that the feeding of whole 
prey modulates hindgut fermentation towards gastrointestinal 
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health in the captive cheetah. However, there is a dearth of data 
on the functionality of fermentation products in felids (Rondeau et 
al. 2003) and many other mammals, with current research typically 
restricted to studies in rats, humans or in vitro. Therefore, the 
relevance of changes in fermentation pattern to gastrointestinal 
health of cheetahs is still unknown.
In exotic felids, faecal consistency is often used to assess 
intestinal health. However, scientific evidence of an association 
between faecal consistency measurements and gastrointestinal 
disease is still lacking, and the sensitivity of faecal scoring as a 
marker for gastrointestinal health is questionable. 
The proteins calprotectin (S100A8/S100A9) and S100A12 are 
secreted by activated granulocytes and monocytes during times 
of acute intestinal inflammation, and calprotectin can also be 
produced in epithelial cells at sites of inflammation (Johne et al. 
1997; Roth et al. 2003; Foell et al. 2009). Both faecal proteins 
have been successfully used as markers of gastrointestinal 
inflammation in humans (Fagerhol 2000; Konikoff et al. 2006; Foell 
et al. 2009) and their validity is currently being evaluated in dogs 
(Grellet et al. 2011; Heilmann et al. 2012a; Otoni et al. 2012). The 
current study was therefore designed to evaluate faecal as well 
as serum calprotectin and S100A12 as potential biomarkers of 
gastrointestinal health in captive cheetahs fed either a whole prey 
or a meat-only diet. 
Methods 
Experimental design 
This experiment was part of a study on the effect of diet type 
on microbial fermentation in the captive cheetah. As such, the 
detailed methodology and diet composition has previously been 
reported (Depauw et al. 2011). In brief, a cross-over study including 
12 clinically healthy cheetahs (4 male, 10 female, 3.0 ± 1.6 years 
old) housed at Ree Park Ebeltoft Safari (Ebeltoft, Denmark) was 
conducted and faecal samples were collected from cheetahs 
consuming two alternative diets. The test diets consisted of 
either unsupplemented whole rabbit (2.5–3 kg diet/animal daily, 
Kiezebrink Putten B.V., Hoge Eng Oost, the Netherlands) without 
additional supplementation, or beef (1.2–1.6 kg diet/animal 
daily, Kiezebrink Putten B.V., Hoge Eng Oost, The Netherlands) 
supplemented with a vitamin and mineral premix (10 g/kg meat 
(as fed), Carnizoo®, Twilmij B.V., Stroe, The Netherlands). 
Before the onset of the trial, all cheetahs were fed mainly on 
supplemented beef. A three-week adaptation period was used 
prior to collection of faeces during the fourth week of each testing 
period. One fresh faecal sample was collected for each individual 
within 15 min of voiding and was immediately frozen and stored at 
-20°C. During the trial, 10 cheetahs were anaesthetised as part of 
the zoo’s routine veterinary plan, and a subsample of serum was 
Table 1. Results of the analytical validation of the canine calprotectin and S100A12 assays for use with serum and faecal extracts from cheetahs.
Dilutional parallelism Spiking recovery (canine protein)
Calprotectin S100A12 Calprotectin S100A12
Sample 
number
Mean 
(μg/L or ng/g) O/E (%) ± SD
Mean 
(μg/L or ng/g) O/E (%) ± SD
Mean 
(μg/L or ng/g) O/E (%) ± SD
Mean 
(μg/L or ng/g) O/E (%) ± SD
S1 2918 120.5 ± 15.8 65 123.1 ± 6.4 1613 133.3 ± 32.3 46 88.9 ± 5.5
S2 1536 113.6 ± 7.8 93 103.9 ± 16.3 2154 114.9 ± 15.9 73 96.7 ± 9.0
S3 2023 101.6 ± 6.2 115 108.5 ± 16.5 3190 112.0 ± 14.3 126 90.4 ± 3.5
S4 2953 114.8 ± 20.5 184 104.2 ± 21.2 2103 113.3 ± 14.8 199 92.9 ± 3.8
F1 5197 103.6 ± 7.5 155 118.1 ± 5.7     2949 178.9 ± 73.5 505 94.7 ± 4.1
F2 5881 114.2 ± 9.8 146 104.6 ± 4.6     6498 130.2 ± 35.3 166 88.8 ± 3.2
F3 5009 115.2 ± 13.9 826 111.6 ± 1.8     5572 150.7 ± 42.7 825 94.6 ± 4.8
F4 2256 104.3 ± 16.8 181 108.2 ± 1.0     12260 116.3 ± 20.7 1589 95.4 ± 5.6
O/E(%) = percentage recovery calculated as [(observed concentration × 100)/expected concentration]; SD = standard deviation.
Intra-assay variability Inter-assay variability
Calprotectin S100A12 Calprotectin S100A12
Sample 
number
Mean 
(μg/L or ng/g)
CV (%)
Mean 
(μg/L or ng/g)
CV (%)
Mean (
μg/L or ng/g)
CV (%)
Mean 
(μg/L or ng/g)
CV (%)
S1 1007 5.5 51 8.4 1118 7.1 53 3.4
S2 2272 3.8 66 2.4 1491 6.4 71 3.5
S3 2892 8.5 104 3.4 2271 9.3 111 3.7
S4 1693 5.1 150 4.5 1523 8.0 191 4.3
F1 2752 5.0 503 2.7 1376 28.5 544 4.5
F2 13368 5.6 129 4.1 10726 12.8 186 8.2
F3 5573 3.0 694 2.8 4232 5.8 737 5.3
F4 5847 4.6 1291 2.8 3627 14.0 1261 4.3
CV = coefficient of variation
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donated to this study. As a result, serum was collected from four 
cheetahs fed whole rabbit and six cheetahs fed supplemented 
beef. The samples were centrifuged and serum was immediately 
frozen and stored at -20°C until analysis.
Faecal/serum calprotectin and S100A12 analyses
Faecal samples were thawed and 1 g was diluted 1:5 in faecal 
extraction buffer (20 mM CH
3CO2 and 3 mM CaCl2 [pH 7,6]) containing 
an EDTA-free proteinase inhibitor cocktail (1 tablet/25mL, Roche 
Diagnostics GmbH, Mannheim, Germany). The samples were then 
vigorously shaken (30 min, 23°C) and centrifuged (20 min, 5°C, 
2100 x g). Finally, the supernatant was collected by use of a serum 
filter (Fisherbrand serum filter system [IB model], Fisher Scientific 
Inc., Pittsburgh, USA) and again centrifuged (30 min, 23°C, 
10,600 x g). Calprotectin and S100A12 concentrations in faecal 
extracts and serum were measured by in-house ELISAs according 
to Heilmann et al. (2011b; 2012a). The assays were analytically 
validated for the quantification of both markers in serum and 
faecal samples from cheetahs by determination of dilutional 
parallelism, spiking recovery, and intra- and inter-assay variability 
using four different sera and four faecal extracts from cheetahs 
for each. Dilutional parallelism was determined by evaluating sera 
and faecal extracts at a serial 2-fold dilution from 1:50–1:400 and 
1:100–1:800, respectively. The remaining validation parameters 
were determined with serum samples diluted 1:100 and a 
final dilution of 1:500 for faecal extracts. Spiking recovery was 
determined by adding purified canine calprotectin (0, 0.5, 1, 2, 5, 
10 and 25 ng/mL) or canine S100A12 (0, 0.05, 0.1, 0.2, 0.5, 1.0 and 
2.5 ng/mL) to each of the samples and calculating the percentage 
of antigen recovery. Further, five different serum samples and five 
different fecal extracts were spiked with each other. Calprotectin 
and S100A12 were measured in each of the spiked and unspiked 
samples and the percentage of recovery was calculated. Intra-
assay variability was evaluated by assaying each sample 10 times 
within the same assay and calculating the intra-assay coefficients 
of variation (%CV) for each sample. Inter-assay variability of the 
assay was determined by analysing each sample in 10 consecutive 
assay runs and calculating inter-assay %CVs.
Data analysis
Data were analysed using IBM SPSS version 20 (IBM SPSS Statistics, 
IBM Inc, Armonk, NY, USA). Following distribution analysis (using 
a Shapiro-Wilk test), median values (lower quartile Q
1, upper 
quartile Q3) were reported for the nonparametric data. 
Spearman correlation coefficients were used to evaluate 
the associations among faecal as well as serum calprotectin 
and S100A12 concentrations. Further, concentrations of both 
calprotectin and S100A12 in faeces and in serum were compared 
within individual animals using a Spearman’s test.
A Wilcoxon signed rank test was performed to evaluate the effects 
of test diet on faecal calprotectin and S100A12 concentrations. 
Differences in serum concentrations of calprotectin and S100A12 
between diets were evaluated using a Mann-Whitney U Test. 
Statistical significance was set at P ≤ 0.05.
Results 
Both the assay for canine calprotectin and for canine S100A12 
detected the respective analytes in serum and faecal samples 
collected from cheetahs. The dilutional parallelism, spiking 
recovery, intra-assay and inter-assay variability are summarised in 
Tables 1 and 2. Of note, faecal calprotectin concentrations did not 
consistently parallel the standard curve of the calprotectin assay 
in some of the samples from cheetahs, especially for samples with 
a high concentration of calprotectin. Likewise, an over-recovery 
was detected in faecal samples from cheetahs spiked with canine 
calprotectin, especially samples with a low concentration of 
calprotectin.
Faecal calprotectin and S100A12 were positively correlated 
(r = 0.918, P<0.001). Likewise, serum calprotectin and S100A12 
correlated positively (r = 0.967, P<0.001). However, faecal 
Table 2. Recovery of calprotectin and S100A12 in serum samples and 
faecal extracts from cheetahs, spiked among each other. 
Spiking recovery (samples)
Calprotectin S100A12
Sample 
number
Concentration 
(μg/L or ng/g)
O/E(%)
Concentration 
(μg/L or ng/g)
O/E(%)
S1+S2 4773 98.4 121 106.2
S1+S3 3887 94.4 103 109.4
S1+S4 3655 94.9   95 104.9
S1+S5 3410 88.9 101 109.7
S2+S3 3123 95.4   70 102.3
S2+S4 2708 90.2   66 102.6
S2+S5 2927 97.9   74 111.5
S3+S4 2099 92.4   47 106.0
S3+S5 2113 93.6   47 102.2
S4+S5 1821 91.7   42 100.4
All 93.8 ±  3.1 105.5 ±  3.7
F1+F2 38566 89.3 2241 101.9
F1+F3 36468 95.8 1864 105.8
F1+F4 31044 90.1 1828 109.3
F1+F5 28307 87.4 1819   95.8
F2+F3 17268 85.8    654 101.1
F2+F4 15065 91.1    552   98.9
F2+F5 12725 87.9    737   93.9
F3+F4 11926 104.6    149 123.5
F3+F5 11450 122.4    350 101.1
F4+F5 5896 102.5    284 109.9
All 95.7 ±11.4 104.1 ±  8.6
O/E (%) = percentage recovery calculated as [(observed concentration × 
100) /expected concentration]
Table 3. Calprotectin and S100A12 concentrations in faeces and serum 
from cheetahs fed whole rabbit or supplemented beef for a period of 1 
month.  Values presented as median (Q1, Q3); Q1 = lower quartile, Q3 = 
upper quartile.
Whole rabbit Supplemented beef P
n 12 12
Faecal calprotectin 
(μg/g) 1.3 (0.04, 7.8) 8.8 (2.8, 24.4) 0.241
Faecal S100A12 (ηg/g) 301 (223, 1185) 1671 (494, 4415) 0.041
n 4 6
Serum calprotectin 
(μg/L) 2755 (1798, 4093) 2104 (1580, 2184) 0.257
Serum S100A12 (μg/L) 117 (85, 207) 96 (76, 107) 0.476
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concentrations of both calprotectin and S100A12 did not correlate 
with the concentrations of these proteins in serum. 
Concentrations of calprotectin and S100A12 in faeces and serum 
collected from captive cheetahs are presented in Table 3. The 
marked numerical increase in faecal calprotectin concentration in 
cheetahs when fed supplemented beef failed to reach the level 
of significance. Cheetahs fed whole rabbit exhibited significantly 
lower faecal S100A12 concentrations (median: 301 ng/g, Q
1 223, 
Q3 1185) compared to the same cheetahs fed supplemented beef 
(median: 1671 ng/g, Q1 494, Q3 4415, P=0.041). The individual 
changes of faecal calprotectin and S100A12 are presented in 
Figure 1, respectively Figure 2.
No significant differences were detected between the diet 
groups in serum calprotectin or S100A12. 
Discussion
The pro-inflammatory proteins calprotectin (S100A8/S100A9) 
and S100A12 have been extensively studied for their use as faecal 
biomarkers in inflammatory bowel disease (IBD) in humans (Røseth 
et al. 1992; Costa et al., 2003; Foell et al., 2009). Given their value 
as sensitive markers for clinical as well as subclinical intestinal 
inflammation (Foell et al. 2003; D’Inca et al. 2008), the utility of 
calprotectin and S100A12 in the diagnosis and/or monitoring of 
canine IBD is currently under investigation (Grellet et al. 2011; 
Heilmann et al. 2012a,b; Otoni et al. 2012). However, faecal 
calprotectin and S100A12 are non-specific markers of intestinal 
inflammation, and as such, these markers in isolation may not 
differentiate IBD from other intestinal inflammatory conditions 
(Summerton et al. 2002).
Both the immunoassay for canine calprotectin and canine 
S100A12 were precise and reproducible for use with serum 
samples and faecal extracts from cheetahs, and the assay for 
S100A12 was also linear and accurate for serum samples and 
faecal extracts from cheetahs. However, the canine calprotectin 
assay showed an inconsistent linearity together with an apparent 
over-recovery of spiked canine calprotectin in samples with a 
low analyte concentration. However, these deviations were not 
present in samples that were spiked with other serum or faecal 
samples from cheetahs, and therefore, these results are consistent 
with a lower avidity of the antibodies generated against canine 
calprotectin for the homologous protein in the cheetah. Whilst 
for the generation of these initial data, the use of the canine 
calprotectin assay for serum and faecal samples from cheetahs 
was deemed appropriate, further studies into calprotectin in 
cheetahs may require a species-specific assay. 
Faecal concentrations of calprotectin and S100A12 were highly 
variable among cheetahs, paralleling findings in dogs (Heilmann 
et al. 2008, 2011a,b). Ideally, faecal concentrations of these 
biomarkers should be quantified in 3-day sample collections 
(Heilmann et al. 2008), however, only 1-day sample collections 
were available for this study. Cheetah 3 showed, when fed whole 
rabbit, markedly higher faecal concentrations of both markers 
compared to the other cheetahs, without any clinical signs of 
compromised gut health. Although an analytical error could not be 
totally ruled out, cheetah 3 was not excluded from the dataset in 
this early stage of evaluating S100/calgranulins in an exotic felid.
Faecal calprotectin concentrations were not significantly 
different between diet groups. However, whereas calprotectin 
concentrations in cheetahs fed supplemented beef were within 
the same range as reported for healthy dogs using the same 
assay (3.2–65.4 μg/g, Heilmann et al. 2011b), the whole rabbit 
diet resulted in markedly lower calprotectin values as compared 
to previously reported concentrations in dogs. Compared to 
calprotectin, faecal S100A12 did differ between diet groups. 
Cheetahs fed supplemented beef had significantly higher faecal 
S100A12 concentrations compared to when fed whole rabbit. 
In addition, faecal S100A12 concentrations in cheetahs fed beef 
exceeded the central 95th percentile of a single day faecal collection 
in healthy dogs (2–1575 ng/g, Heilmann et al. 2012a), which may 
indicate on-going inflammatory conditions.
Simultaneously with the present study, the intestinal 
fermentation profile of these cheetahs on both diet types was 
examined (Depauw et al. 2011). Cheetahs fed a supplemented 
beef diet were observed to have significantly higher concentrations 
of putrefactive compounds, accompanied by looser stool and a 
higher incidence of diarrhoea compared to the same cheetahs fed 
whole rabbit. This difference is probably due to a combination of a 
higher protein intake and lower animal fibre content in meat-only 
diets compared with whole prey (Depauw et al. 2011, 2012). The 
significantly higher faecal S100A12 concentrations in cheetahs fed 
beef, compared with whole rabbit, strengthen the assumption 
that the higher incidence of putrefactive compounds and looser 
stool is indicative of compromised gut health in the cheetah. 
To further evaluate the association between putrefactive 
compounds and intestinal inflammation, and to broaden our 
insight into gut health assessment, we examined the possible 
correlation between faecal S100A12 and calprotectin, faecal 
scores (Depauw et al. 2011) and faecal fermentation metabolites 
(Depauw et al. 2011). No significant correlations (data not shown) 
between these parameters were present, which is possibly due to 
the small number of studied cheetahs. 
Recent studies revealed that faecal S100A12 has an improved 
diagnostic accuracy and a higher correlation to intestinal mucosal 
inflammation compared to faecal calprotectin in humans (Kaiser 
et al. 2007; Leach et al. 2007; Sidler et al. 2008). This might 
explain why faecal S100A12 concentrations, but not calprotectin 
concentrations, were significantly elevated in cheetahs fed a 
meat-only diet compared to whole rabbit diet for only one month. 
Figure 1. Individual faecal calprotectin concentrations in faeces from 
cheetahs fed whole rabbit or supplemented beef for a period of 1 month.
Figure 2. Individual faecal S100A12 concentrations in faeces from cheetahs 
fed whole rabbit or supplemented beef for a period of 1 month.
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Given the limitations of the calprotectin assay, however, the lack 
of a significant difference in faecal calprotectin concentrations 
between the two dietary groups needs to be interpreted with 
caution. 
Although blood concentrations of calprotectin and S100A12 
have been reported as useful markers of intestinal inflammation 
(Foell et al. 2003; Heilmann et al. 2012b), increased serum 
concentrations occur in several disease conditions, particularly in 
inflammatory diseases, certain microbial infections, and neoplastic 
conditions (Johne et al. 1997; Striz and Trebichavsky 2004). At 
present, no studies have evaluated the relationship between 
serum and faecal concentrations of calprotectin or S100A12. In the 
current study, serum concentrations of neither marker correlated 
with their faecal concentrations. Moreover, serum concentrations 
were unaffected by diet and comparable with concentrations 
detected in healthy dogs (969–11,873 μg/L, Heilmann et al. 2011b 
and 57–326 μg/L, respectively, Heilmann et al. unpublished). It 
is possible that the feeding trial was too short to elicit changes 
in blood concentrations of these markers or that the sample size 
was inadequate. However, it is likely that serum calprotectin and 
S100A12 are less specific markers for intestinal inflammation, 
which warrants further investigation and the establishment of 
normal serum calprotectin and S100A12 concentrations in a larger 
sample of healthy cheetahs. 
Conclusion
In the cheetah, faecal calprotectin and S100A12 concentrations 
were measured using ELISA assays that were previously 
analytically validated for dogs. These proteins are promising 
markers for future research on intestinal inflammation in the 
cheetah. Our results indicate that the type of diet affects faecal 
but not serum concentrations of S100/calgranulins in the captive 
cheetah. Significantly lower faecal S100A12 and numerically lower 
calprotectin concentrations were detected when cheetahs were 
fed whole rabbit compared with supplemented beef. Consequently, 
the diet type provided (whole prey or meat-only) can potentially 
affect intestinal inflammatory conditions in the captive cheetah. In 
light of the disproportionately high prevalence of gastrointestinal 
disease in cheetahs held in captivity, these findings warrant further 
investigation. 
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